Épisode
Colloque – La neurotechnologie : Scaling Neurotechnologies: The Interplay of Ethical, Regulatory and Market Dynamics
Stéphanie LacourCollège de FranceInnovation technologique Liliane Bettencourt (2023-2024)Année 2023-2024Colloque - La neurotechnologie : Scaling Neurotechnologies: The Interplay of Ethical, Regulatory and Market DynamicsInnovating Responsibly: Neurotechnology Standards and Societal EthicsColloque coorganisé par Stéphanie Lacour, chaire Innovation technologique Liliane Bettencourt et Mme Karen Rommelfanger.Intervenant(s)Olivier Oullier, Co-founder, Inclusive Brains & Chairman, Institute for...
Afficher plus
Stéphanie Lacour
Collège de France
Innovation technologique Liliane Bettencourt (2023-2024)
Année 2023-2024
Colloque - La neurotechnologie : Scaling Neurotechnologies: The Interplay of Ethical, Regulatory and Market Dynamics
Innovating Responsibly: Neurotechnology Standards and Societal Ethics
Colloque coorganisé par Stéphanie Lacour, chaire Innovation technologique Liliane Bettencourt et Mme Karen Rommelfanger.
Intervenant(s)
Olivier Oullier, Co-founder, Inclusive Brains & Chairman, Institute for Artificial Intelligence by Biotech Dental
As neurotechnologies transition from research labs to mainstream markets, they encounter a complex array of ethical considerations, regulatory frameworks, and market dynamics. The ethical and regulatory responses to the swift deployment of AI-powered neurotech are continually evolving. In this presentation, Oullier will build on his expertise in academia, policymaking, and business to champion proactive engagement with all stakeholders. This approach aims to ensure that the commercial expansion of neurotechnologies aligns with societal values and ethical principles, enhancing human capabilities while safeguarding fundamental rights. Additionally, he will address the risks posed by unregulated commercial practices as well as by poorly informed individuals involved in ethics and regulatory initiatives who are making non-evidence-based claims that could hinder both research and business progress in AI and neurotechnologies.
Pas de transcription pour le moment.
Notes et Commentaires
(0)
Évaluer l'épisode
